Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program

OBJECTIVE: To evaluate effects of the dual sodium–glucose cotransporter (SGLT) 1 and SGLT2 inhibitor sotagliflozin in combination with insulin on glucose time in range (TIR) and glucose excursions, postprandial glucose (PPG), and other glycemic metrics in adults with type 1 diabetes using masked con...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Diabetes Care
Egile Nagusiak: Danne, Thomas, Cariou, Bertrand, Buse, John B., Garg, Satish K., Rosenstock, Julio, Banks, Phillip, Kushner, Jake A., McGuire, Darren K., Peters, Anne L., Sawhney, Sangeeta, Strumph, Paul
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Diabetes Association 2019
Gaiak:
Emerging Therapies: Drugs and Regimens
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6905498/
https://ncbi.nlm.nih.gov/pubmed/30833371
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc18-2149
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak